Skip to content
Delayed ~15 min

PTCT PTC THERAPEUTICS

Permanent stock page ↗

Health Care · Russell 2000

Next earnings: not announced yet

What 17 analyst firms say about PTC THERAPEUTICS: their latest ratings, price targets and how far the stock is from them. How it works

65.44 USD−0.23 (−0.35%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+50.2%to the avg target 98.27 USD+32.83 USD
Buy 12 · Hold 3 · Sell 1

16 rated views · 18 analyst/firm records · 17 firms

Latest report30 Oct 2026avg report date 20 Aug
Target rangeLowest to highest analyst target, not a forecast

Radar score

  • Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8067
  • Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8061

Recent analyst activity · last 90 days

Our tracked history has 16 reports on PTCT from 12 analyst firms in the last 90 days (17 firms in the past year).

Comparing each firm's latest target with its previous one: 5 raised their price target, 1 lowered it, 1 left it unchanged and 4 have their first observed target in the past year.

No firm's latest available rating differs from its previous one.

Latest observed target change: Citigroup raised its target from $108.00 (set 9 Jun 2026) to $109.00 on 2 Nov 2026.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
BairdLuke HerrmannBuy1 Sep 202692.00 USD
Bank of America SecuritiesTazeen AhmadBuy20 Feb 202693.00 USD
BarclaysEliana MerleBuy14 Aug 2026122.00 USD
Cantor FitzgeraldKristen KluskaBuy22 Sep 2026137.00 USD
CitigroupEric JosephBuy9 Jun 2026108.00 USD
CitigroupGeoff MeachamBuy9 Jun 2026108.00 USD
Goldman SachsPaul K ChoiSell30 Apr 202670.00 USD
JefferiesFaisal KhurshidBuy27 May 2026Conflicting reports · excluded
Leerink PartnersBasma RadwanBuy14 Sep 202698.00 USD
Morgan StanleyJudah FrommerBuy31 Jul 2026104.00 USD
Raymond JamesTiago FauthConflictConflicting reports · excluded20 Oct 2026106.00 USD
RBC Capital MarketsBrian AbrahamsHold30 Oct 202677.00 USD
TD CowenJoseph ThomeBuy30 Oct 202695.00 USD
TruistAlex NackenoffHold16 Oct 202662.00 USD
UBSJoon LeeBuy15 Oct 202690.00 USD
Weiss RatingsUnnamed analyst—8 Oct 2026—
Wells FargoBenjamin BurnettBuy30 Oct 2026112.00 USD
Data feed RESEARCHResearch TeamHold6 Aug 2026—

Partial coverage · checked 6 Nov (6 Nov 2026, 04:10 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.